Latest Regulatory Developments News

Bioxyne Limited has reported a record quarterly revenue of A$14.1 million for Q1 FY26, driven by strong demand in Europe and Australia, alongside a strategic dual listing on the Frankfurt Stock Exchange.

Little Green Pharma reported a robust September quarter with revenue exceeding $10 million, driven by growth across all product lines and strong European market performance. The company is poised to benefit from upcoming regulatory reforms and operational efficiencies.

Haranga Resources has completed its acquisition of the Lincoln Gold Project in California and reported high-grade gold results from its Senegal project, backed by a $14 million capital raise to fast-track exploration and development.

Metals X reported a 16.6% decline in tin production at its Renison operation for Q3 2025 due to equipment and processing challenges, while cash reserves rose to $279.5 million. The company continues advancing its Rentails project and maintains strategic investments.

Ainsworth Game Technology’s board unanimously backs Novomatic’s $1.00 per share takeover offer, while a competing proportional bid at $1.30 per share emerges from a key shareholder.

MyEco Group reported a modest 2% sales increase in Q1 FY26, driven by strong council channel growth that offsets U.S. tariff-related setbacks. Operational restructuring and regulatory tailwinds underpin its medium-term outlook.

Coast Entertainment’s Dreamworld development application has been called-in by the Queensland Minister, while the company reports robust FY26 trading growth and nears completion of its new King Claw ride.

Aeris Resources has agreed to sell its North Queensland copper assets to Dingo Minerals for up to $15.5 million, marking a strategic move to focus on core operations and strengthen its balance sheet.

Smartpay Holdings has secured final court approval for its acquisition by Shift4 Holdings, setting the stage for share suspension and delisting in early November. Shareholders will receive NZ$1.20 per share in cash upon completion, pending final conditions.

Abbott has received Overseas Investment Office approval to acquire Synlait Milk’s North Island manufacturing and warehouse facilities in a US$178 million deal, pending shareholder consent.

EDU Holdings reports a 26% rise in new student enrolments for Term 4, 2025 compared to the prior term, signaling resilience amid sector softness and recent regulatory changes.

Singular Health Group has advanced its US expansion through the deployment of 3DICOM™ licenses under a key contract with Provider Network Solutions, alongside appointing a new US commercial chief to drive growth.